Magnolia Medical

Seattle

Magnolia Medical is an organization focused on reducing contamination during blood tests and has raised $46 million to fuel growth.

Facts

HQ
Seattle
Sectors
Medical devices, Diagnostics, Healthcare

Is this your organization? Claim it

GeekWire 200 update: Remitly No. 3 as proposed IPO looms; Hootsuite debuts No. 6, Convoy rises to No. 7

GeekWire updated its GeekWire 200 list highlighting Pacific Northwest private tech startups amid record investment and M&A activity, with trends toward virtual experiences, at-home healthcare, remote education, and e-commerce. Notable rankings: Remitly at No. 3 (last valued $1.5B, proposed IPO), Hootsuite debuted at No. 6, Convoy rose to No. 7 (valued $2.75B in 2019), and Fabric jumped 26 spots to No. 95.

Magnolia Medical raises $20M led by RTW to expand Steripath and cut sepsis blood-test false positives by 85%

Magnolia Medical raised $20 million led by RTW Investments to expand its Steripath platform and develop products that reduce false positives in sepsis blood tests; the company says Steripath can cut false positives by more than 85% and offers a money-back guarantee. The round included HealthQuest Capital, SightLine Partners and Canepa Healthcare, brings Magnolia’s total funding to $50 million, and adds RTW partner Naveen Yalamanchi, M.D., to the board.

See all 4 stories, episodes and videos about Magnolia Medical.